Online Education | Diabetes Update 2017 - DCCT/EDIC: Answering Type 1 Diabetes Questions for Over 30 Years (Rx)
In 1983, Jerry Palmer was a part of the group studying type 1 diabetes in the Diabetes Control and Complications Trial (DCCT) that tested the "glucose hypothesis" and the Epidemiology of Diabetes Interventions and Complications (EDIC) study, following the DCCT subjects over 30 years. Now, three decades later, Dr. Palmer shares the lessons learned from DCCT/EDIC, and their relevance to current knowledge about type 1 diabetes.
Jerry P. Palmer, MD
Professor, Medicine, UW; Chief, Division of Endocrinology/Metabolism, VA Puget Sound Health Care System, Seattle
Comments from lecture attendees:
"Dr. Jerry Palmer’s 11-point DCCT/ EDIC summary was brilliantly clear and helpful."
"Thank you for explaining the study, I finally understand the importance of it! Great talk and interesting info."
Watch a preview
For nurses, nurse practitioners, nurse educators, certified diabetes educators, dietitians, nutritionists, pharmacists, social workers, health educators, physical therapists and other healthcare professionals across all settings.
Objectives for Learning Outcomes
After taking this module, you will be better able to:
- Recognize the importance of residual beta cell function in type 1 diabetes (T1D).
- Describe metabolic memory in the treatment of type 1 diabetes.
- Discuss the relationship of glycemic control to mortality risk in type 1 diabetes.
- 1.00 Contact hours
- 1.00 Pharmacology hours at the advanced practice level